Home

PDAC

• PREVALENCE
• RAS IN ONCOGENESIS
• RAS MUTATIONS
• CHALLENGES IN PDAC
• POTENTIAL OF TARGETING RAS

NSCLC

• PREVALENCE
• RAS HETEROGENEITY
• RAS IN ONCOGENESIS
• CHALLENGES IN NSCLC